US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 3.5000
  • +0.2818+8.76%
Close Apr 19 16:00 ET
  • 3.2300
  • -0.2700-7.71%
Post 16:57 ET
9.49MMarket Cap-1555P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
-91.05%297K
0
0
-97.60%72K
262.90%225K
Operating revenue
--0
--0
--0
--0
--0
-91.05%297K
--0
--0
-97.60%72K
262.90%225K
Cost of revenue
Gross profit
Operating expense
-48.79%9.65M
-59.71%1.8M
-40.00%2.71M
-68.58%4.24M
-46.69%7.04M
-67.32%18.84M
-69.32%4.46M
-60.24%4.52M
-26.18%13.51M
-1.84%13.21M
Selling and administrative expenses
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-4.66%3.36M
-17.28%3.27M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
-43.58%3.52M
-26.34%3.95M
-General and administrative expense
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-4.66%3.36M
-17.28%3.27M
-37.64%12.86M
-25.70%3.28M
-32.54%3.1M
-43.58%3.52M
-26.34%3.95M
Research and development costs
-74.66%1.52M
-97.96%24K
-58.98%580K
-91.33%886K
-61.27%3.77M
-84.11%5.98M
-88.76%1.18M
-79.89%1.41M
-15.23%10.22M
20.40%9.74M
Other operating expenses
----
----
----
----
----
----
----
----
---234K
---486K
Operating profit
47.97%-9.65M
59.71%-1.8M
40.00%-2.71M
68.41%-4.24M
45.76%-7.04M
65.87%-18.54M
68.93%-4.46M
59.96%-4.52M
12.17%-13.43M
3.07%-12.98M
Net non-operating interest income expense
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
1,366.67%88K
1,937.50%294K
13,300.00%132K
2,320.00%111K
850.00%45K
250.00%6K
Non-operating interest income
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
----
--294K
--132K
--111K
--45K
----
Total other finance cost
----
----
----
----
-1,366.67%-88K
----
----
----
----
-250.00%-6K
Other net income (expense)
-3.3M
0
-3.3M
Special income (charges)
---3.3M
--0
---3.3M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--3.3M
--0
--3.3M
----
----
--0
--0
--0
----
----
Income before tax
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
68.77%-4.18M
46.42%-6.95M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
17.27%-13.39M
3.14%-12.98M
Income tax
Net income
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
3.14%-12.98M
Net income continuous Operations
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
68.77%-4.18M
46.42%-6.95M
64.67%-18.25M
59.88%-4.32M
60.97%-4.41M
17.27%-13.39M
3.14%-12.98M
Net income discontinuous operations
128.38%7.33M
--0
321.28%13.47M
----
----
---25.83M
---2.89M
---6.09M
----
----
Minority interest income
Net income attributable to the parent company
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
3.14%-12.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.03%-10.5M
17.27%-13.39M
3.14%-12.98M
Basic earnings per share
88.91%-2.25
78.92%-0.7
164.39%3.11
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
31.56%-6.16
23.08%-6
Diluted earnings per share
88.91%-2.25
78.92%-0.7
156.31%2.72
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
7.12%-4.83
31.56%-6.16
23.08%-6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 00000-91.05%297K00-97.60%72K262.90%225K
Operating revenue --0--0--0--0--0-91.05%297K--0--0-97.60%72K262.90%225K
Cost of revenue
Gross profit
Operating expense -48.79%9.65M-59.71%1.8M-40.00%2.71M-68.58%4.24M-46.69%7.04M-67.32%18.84M-69.32%4.46M-60.24%4.52M-26.18%13.51M-1.84%13.21M
Selling and administrative expenses -36.76%8.13M-45.99%1.77M-31.35%2.13M-4.66%3.36M-17.28%3.27M-37.64%12.86M-25.70%3.28M-32.54%3.1M-43.58%3.52M-26.34%3.95M
-General and administrative expense -36.76%8.13M-45.99%1.77M-31.35%2.13M-4.66%3.36M-17.28%3.27M-37.64%12.86M-25.70%3.28M-32.54%3.1M-43.58%3.52M-26.34%3.95M
Research and development costs -74.66%1.52M-97.96%24K-58.98%580K-91.33%886K-61.27%3.77M-84.11%5.98M-88.76%1.18M-79.89%1.41M-15.23%10.22M20.40%9.74M
Other operating expenses -----------------------------------234K---486K
Operating profit 47.97%-9.65M59.71%-1.8M40.00%-2.71M68.41%-4.24M45.76%-7.04M65.87%-18.54M68.93%-4.46M59.96%-4.52M12.17%-13.43M3.07%-12.98M
Net non-operating interest income expense 21.77%358K-23.48%101K-3.60%107K37.78%62K1,366.67%88K1,937.50%294K13,300.00%132K2,320.00%111K850.00%45K250.00%6K
Non-operating interest income 21.77%358K-23.48%101K-3.60%107K37.78%62K------294K--132K--111K--45K----
Total other finance cost -----------------1,366.67%-88K-----------------250.00%-6K
Other net income (expense) -3.3M0-3.3M
Special income (charges) ---3.3M--0---3.3M----------0--0--0--------
-Less:Impairment of capital assets --3.3M--0--3.3M----------0--0--0--------
Income before tax 30.98%-12.59M60.81%-1.69M-34.06%-5.91M68.77%-4.18M46.42%-6.95M64.67%-18.25M59.88%-4.32M60.97%-4.41M17.27%-13.39M3.14%-12.98M
Income tax
Net income 88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M3.14%-12.98M
Net income continuous Operations 30.98%-12.59M60.81%-1.69M-34.06%-5.91M68.77%-4.18M46.42%-6.95M64.67%-18.25M59.88%-4.32M60.97%-4.41M17.27%-13.39M3.14%-12.98M
Net income discontinuous operations 128.38%7.33M--0321.28%13.47M-----------25.83M---2.89M---6.09M--------
Minority interest income
Net income attributable to the parent company 88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M3.14%-12.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.03%-10.5M17.27%-13.39M3.14%-12.98M
Basic earnings per share 88.91%-2.2578.92%-0.7164.39%3.1170.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.8331.56%-6.1623.08%-6
Diluted earnings per share 88.91%-2.2578.92%-0.7156.31%2.7270.29%-1.8346.67%-3.223.18%-20.2830.83%-3.327.12%-4.8331.56%-6.1623.08%-6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg